Compounds > azacitidine

azacitidine and Triple Negative Breast Neoplasms

azacitidine has been researched along with Triple Negative Breast Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Qin, B; Wang, L; Yu, J; Zayas, J1
Al-Moghrabi, N; Al-Shahrani, B; Al-Showimi, M; Al-Yousef, N; Shinwari, Z1
Crans, RAJ; Declerck, K; Diddens, J; Gerhäuser, C; Scherf, DB; Szarc Vel Szic, K; Vanden Berghe, W1
Kumar, S; Surapaneni, SK; Thummuri, D; Tikoo, K1
Ding, L; Jin, LY; Kong, B; Lv, ZD; Wang, Y; Yang, ZC1
Broggini, M; Cavalli, IJ; Chilà, R; Damia, G; de Lima, RS; de Oliveira, SF; Ganzinelli, M; Generali, D; Maciel, ME; Ribeiro, EM; Serino, L; Urban, Cde A1
Ansari, KI; Chen, MY; Choy, C; Jandial, R; Levy, DM1

Other Studies

7 other study(ies) available for azacitidine and Triple Negative Breast Neoplasms

ArticleYear
Targeting DNA methylation for treating triple-negative breast cancer.
    Pharmacogenomics, 2019, Volume: 20, Issue:16

    Topics: Animals; Azacitidine; Cell Line, Tumor; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Promoter Regions, Genetic; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays

2019
Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
    Oncology reports, 2020, Volume: 43, Issue:3

    Topics: Azacitidine; BRCA1 Protein; Cell Line, Tumor; Curcumin; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Female; gamma-Synuclein; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Mixed Function Oxygenases; Promoter Regions, Genetic; Proto-Oncogene Proteins; Triple Negative Breast Neoplasms

2020
Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
    Oncotarget, 2017, Jun-20, Volume: 8, Issue:25

    Topics: ADAM Proteins; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cell Movement; Cytokine TWEAK; Decitabine; DNA Methylation; Female; Glutathione Transferase; Humans; Malate Dehydrogenase; MCF-7 Cells; Membrane Proteins; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Triple Negative Breast Neoplasms; Withanolides

2017
Epigenetic regulation of protein tyrosine phosphatase PTPN12 in triple-negative breast cancer.
    Life sciences, 2015, Jun-01, Volume: 130

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Dose-Response Relationship, Drug; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Protein Tyrosine Phosphatase, Non-Receptor Type 12; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Triple Negative Breast Neoplasms

2015
Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:9

    Topics: Adult; Azacitidine; Cell Line, Tumor; Cell Movement; Decitabine; Disease Progression; DNA Methylation; DNA Modification Methylases; Down-Regulation; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Repressor Proteins; RNA Interference; RNA, Messenger; Transfection; Triple Negative Breast Neoplasms

2015
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Azacitidine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Estrogen Receptor alpha; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Methotrexate; Organ Specificity; Promoter Regions, Genetic; Purine-Nucleoside Phosphorylase; Receptor, ErbB-2; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Triple Negative Breast Neoplasms

2016
Astrocyte-induced Reelin expression drives proliferation of Her2
    Clinical & experimental metastasis, 2017, Volume: 34, Issue:2

    Topics: Astrocytes; Azacitidine; Brain Neoplasms; Breast Neoplasms; Cell Adhesion Molecules, Neuronal; Cell Division; Coculture Techniques; Culture Media, Serum-Free; DNA Methylation; Extracellular Matrix Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Nerve Tissue Proteins; Receptor, ErbB-2; Reelin Protein; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Spheroids, Cellular; Transcriptional Activation; Triple Negative Breast Neoplasms; Tumor Cells, Cultured

2017